Benefit of multidisciplinary consultation at initiation of oral antineoplastic agents in metastatic breast cancer patients

被引：0
|
作者：
Morel, Adeline
Jacobs, Margaux
Da Silva, Angelique
Allouache, Djelila
Hrab, Ioana
Segura, Carine
Villemin, Maud
Boscher, Clemence
Johnson, Alison
Ceintre, Charlotte
Charles, Rose-Marie
Lahaye, Francois
Lequesne, Justine
Divanon, Fabienne
Levy, Christelle
Emile, Georges
机构：
来源：
CANCER RESEARCH | 2022年 / 82卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS21-P4-12-05
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P4-12-05
引用
收藏
页数：2
相关论文
共 50 条
  • [11] Clinical benefit of fulvestrant in heavily pretreated patients with metastatic breast cancer
    Scandurra, Giuseppa
    Carillio, Guido
    Aiello, Rosa Anna
    Chiarenza, Maurizio
    Mazzola, Antonella
    Ali, Marco
    Barone, Gloria
    Greco, Filippo
    Caruso, Michele
    ANNALS OF ONCOLOGY, 2007, 18 : 44 - 44
  • [12] Survival benefit of a combined surgical approach in patients with metastatic breast cancer
    Bilani, Nadeem
    Yaghi, Marita
    Singh Jabbal, Iktej
    Elson, Leah
    Elimimian, Elizabeth Blessing
    Liang, Hong
    Nahleh, Zeina
    JOURNAL OF SURGICAL ONCOLOGY, 2021, 124 (08) : 1235 - 1241
  • [13] Pharmacology of antineoplastic agents in older cancer patients
    Lichtman, SM
    Skirvin, JA
    Vernulapalli, S
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2003, 46 (02) : 101 - 114
  • [14] Predicting benefit from fulvestrant in pretreated metastatic breast cancer patients
    Freedman, Orit
    Amir, Eitan
    Dranitsaris, George
    Napolskikh, Julie
    Kumar, Ritu
    Fralick, Michael
    Chia, Stephen
    Petrella, Teresa
    Dent, Susan
    Tonkin, Katia
    Ahmad, Imran
    Rayson, Daniel
    Clemons, Mark
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 118 (02) : 377 - 383
  • [15] Predicting benefit from fulvestrant in pretreated metastatic breast cancer patients
    Orit Freedman
    Eitan Amir
    George Dranitsaris
    Julie Napolskikh
    Ritu Kumar
    Michael Fralick
    Stephen Chia
    Teresa Petrella
    Susan Dent
    Katia Tonkin
    Imran Ahmad
    Daniel Rayson
    Mark Clemons
    Breast Cancer Research and Treatment, 2009, 118 : 377 - 383
  • [16] Neighborhood deprivation index and time to initiation in patients with metastatic breast cancer
    Rajendran, Sneha
    Ren, Dianxu
    Petruzzi, Marina
    Rosenzweig, Margaret
    CANCER RESEARCH, 2024, 84 (09)
  • [17] Oral idarubicin and cyclophosphamide for metastatic breast cancer in elderly patients
    Zaniboni, A
    Bolognesi, A
    Arnoldi, E
    Tabiadon, D
    Barni, S
    Intini, C
    ANTI-CANCER DRUGS, 1998, 9 (04) : 295 - 299
  • [18] Metastatic breast cancer patients' preferences and expectations for oral chemotherapy
    Jaisle, Alyssa
    Fortune, Erica E.
    Jacobs, Jamie
    Saxton, Claire
    Ackourey, Jemeille
    Zaleta, Alexandra K.
    CANCER RESEARCH, 2021, 81 (04)
  • [19] Approved Agents for Metastatic Breast Cancer
    Fornier, Monica N.
    SEMINARS IN ONCOLOGY, 2011, 38 (03) : S3 - S10
  • [20] Impressive survival data with semimetronomic oral chemotherapy with old agents in heavily treated metastatic breast cancer patients
    Mutlu, H.
    Bozcuk, H.
    Ozdogan, M.
    Artac, M.
    Coskun, H. S.
    Kargi, A.
    Uysal, M.
    Savas, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345